MDA (3,4-Methylenedioxyamphetamine (sass))

Category: Psychedelics. Status: Schedule I (research compound).

A close relative of MDMA that leans more psychedelic, with more visuals and a longer, more stimulating effect. Studied historically and known for greater neurotoxicity risk than MDMA.

How it works

Releases serotonin, dopamine and norepinephrine and has direct serotonin receptor activity, giving a mix of empathogenic and psychedelic effects.

Key facts

• Molecular weight: 179.22 g/mol
• Half-life: ~6-8 hours
• Bioavailability: Oral
• Storage: Research/reference only.

Dosing overview

• Typical dose: Varies by individual and setting
• Frequency: Occasional
• Duration: Acute effects last 6-8 hours
• Route: Oral

Protocol notes

• Taken orally as powder or capsule; more visual and longer than MDMA.
• Carries a higher overheating and neurotoxicity risk, so people hydrate sensibly and avoid redosing.

Reported benefits

• More visual than MDMA
• Empathogen-psychedelic blend
• Longer-lasting
• Historic research compound

Possible side effects

• Greater neurotoxicity risk than MDMA
• Overheating
• Raised heart rate and blood pressure
• Low mood afterward

Compare MDA

• MDA vs MDMA
• MDA vs Psilocybin
• MDA vs LSD
• MDA vs Ibogaine
• MDA vs DMT
• MDA vs Ayahuasca

Research and educational reference only. Not medical advice.